Parallel Advisors, LLC Genfit S.A. Call Options Transaction History
Parallel Advisors, LLC
- $4.87 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GNFT
# of Institutions
9Shares Held
55.2KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY27.4KShares$104,7440.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il18.8KShares$71,6740.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P74.64KShares$17,7200.0% of portfolio
-
Ubs Group Ag4.08KShares$15,5890.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ225Shares$8590.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $190M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...